Hot receptors in the brain by Steenland, Hendrik W et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Molecular Pain
Open Access Review
Hot receptors in the brain
Hendrik W Steenland, Shanelle W Ko, Long-Jun Wu and Min Zhuo*
Address: Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada
Email: Hendrik W Steenland - h.steenland@utoronto.ca; Shanelle W Ko - shana.ko@utoronto.ca; Long-Jun Wu - longjun.wu@utoronto.ca; 
Min Zhuo* - min.zhuo@utoronto.ca
* Corresponding author    
Abstract
Two major approaches have been employed for the development of novel drugs to treat chronic
pain. The most traditional approach identifies molecules involved in pain as potential therapeutic
targets and has focused mainly on the periphery and spinal cord. A more recent approach identifies
molecules that are involved in long-term plasticity. Drugs developed through the latter approach
are predicted to treat chronic, but not physiological or acute, pain. The TRPV1 (transient receptor
potential vanilloid-1) receptor is involved in nociceptive processing, and is a candidate therapeutic
target for pain. While most research on TRPV1 receptors has been conducted at the level of the
spinal cord and peripheral structures, considerably less research has focused on supraspinal
structures. This short paper summarizes progress made on TRPV1 receptors, and reviews
research on the expression and function of TRPV1 receptors in supraspinal structures. We suggest
that the TRPV1 receptor may be involved in pain processing in higher brain structures, such as the
anterior cingulate cortex. In addition, some regions of the brain utilize the TRPV1 receptor for
functions apparently unrelated to pain.
Background
The TRPV1 (transient receptor potential vanilloid-1)
receptor was originally isolated using a calcium imaging-
based expression method [1-3]. This receptor is activated
by capsaicin (the pungent ingredient of hot peppers), pro-
tons, and heat (>43°C), and behaves as a non-selective
cationic channel with high permeability for calcium [2-6].
A number of endogenous ligands suggested for these
receptors include: protons, ATP, lipoxygenase products,
anandamide, N-oleoyldopamine, and N-arachidonoyl
dopamine [5-7].
TRPV1 receptor subunits are predicted to have six trans-
membrane spanning domains with an intramembrane
loop connecting the 5th and 6th domains [3]. A variety of
molecules and proteins interact with and/or modulate the
TRPV1 receptor. These include: TRPV3 and phosphitidyli-
nositol-4,5-bisphosphate receptor modulation of capsai-
cin binding [8,9] and interactions with scaffolding and
synaptic vesicle proteins [10,11].
The role of the TRPV1 receptor in pain-related behaviors
has been demonstrated with gene knockout mice [12].
Specifically, these mice showed impairments in their abil-
ity to detect painful heat stimuli, and demonstrated little
thermal hypersensitivity during an inflammation test
[12]. Responses to noxious mechanical stimulation were
not altered by the gene knockout, suggesting a selective
modality for the TRPV1 receptor [12]. While this study
demonstrates that TRPV1 of the dorsal root ganglia (DRG)
neurons modulate nociceptive behaviors, the role of the
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TRPV1 in supraspinal brain structures was not investi-
gated.
Most research on the TRPV1 receptor has been conducted
on spinal cord and peripheral structures [6,13]. In this
review, we highlight studies that report the expression and
function of the TRPV1 receptor in supraspinal structures,
with particular emphasis on brain regions involved in the
processing of pain.
Expression in the brain
A variety of studies have been conducted to determine the
expression profile of the TRPV1 receptor throughout the
brain [3,14-21] (See additional file 1: Table 1). Initial
studies with [3H] resiniferatoxin (RTX), which label
TRPV1 receptors, have shown that TRPV1 is expressed in
the trigeminal ganglia and DRG [15]. However, no TRPV1
receptor expression was detected in the brain. Confirma-
tion of these findings was obtained with northern blot
analysis [3]. Collectively, these results suggest that the
TRPV1 receptor is not expressed in the brain.
Acs et al. [17] established that TRPV1 receptors could be
detected in the preoptic hypothalamus, locus coeruleus,
and ventral thalamus of human and rat brain, using a
modified RTX-labeling technique. The existence of TRPV1
receptors in the brain has been supported numerous times
with assays for both TRPV1 protein and mRNA [14,16,18-
22] (for example, Fig. 1). One of the most comprehensive
studies was conducted by Roberts et al. [18] in which RTX
labeling in the brain of TRPV1 knockout mice was com-
pared to mice with the TRPV1 gene. This study revealed a
wide distribution of TRPV1 receptors in the brain, includ-
ing regions of the cerebral cortex, cerebellum and a variety
of subcortical structures. It should be emphasized that
TRPV1 RNA is approximately 28 times greater in the DRG
than in any other brain region [21]. Thus, the most likely
explanation for the absence of TRPV1 detection in the
brain, described by other investigators [3,15], is that their
assays were not sensitive enough to detect the lower
expression in the brain.
The TRPV1 receptor is localized to neuron cell bodies and
dendrites, astrocytes, and perivascular structures within
the brain [14,16,18,19]. TRPV1 can be detected predomi-
nantly on postsynaptic spines at the subcellular level [19].
In addition, TRPV1 can be detected in pericytes and at the
feet of astrocytes surrounding small vessels [19]. It has
also been demonstrated that TRPV1 co-localizes and
physically interacts with TRPV2 receptors within the brain
[14]. These two receptors were found to be extensively co-
localized within the cytoplasmic component and plasma
membrane of cortical neurons [14]. In contrast, there was
much less co-localization of TRPV1 and TRPV2 receptors
reported for DRG neurons [14]. Another point of depar-
ture between TRPV1 expression in the DRG and the brain
is that, neonatal capsaicin treatment in rats reduces
expression of TRPV1 mRNA in the DRG, but not in the
brain [16]. The authors suggested that neonatal capsaicin
treatment may deplete neurotrophic factors which are
required for the survival of peripheral neurons and not
central neurons [16]. A more recent finding demonstrated
that a high dose of capsaicin to cultured mesencephalic
dopaminergic neurons induces cell death [23]. The cell
death was likely a consequence of calcium entry leading to
mitochondrial damage [23]. Thus capsaicin can destroy
central neurons, suggesting that neonatal capsaicin treat-
ments may not reach toxic levels in supraspinal structures.
Since the TRPV1 receptor is activated by capsaicin and is
involved in nociceptive processing at the level of the DRG
Expression of TRPV1 in the cortex Figure 1
Expression of TRPV1 in the cortex. A. Cortical immu-
nostaining for the TRPV1 receptors in the rat cortex, with 
each layer indicated (I-V). B. Enlargement of cortical layer V 
(from A) with arrows indicating pyramidal cells. Reprinted 
from [19] © 2005 with permission from Elsevier Science.
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and sensory nerve endings, it is likely that this receptor
occupies a role in pain processing at other brain regions.
Such regions might include: the rostral ventromedial
medulla, periaqueductal grey, solitary tract nucleus
(NTS), preoptic hypothalamus, ventral thalamus, somato-
sensory cortex, anterior cingulate cortex (ACC), and insula
[24,25]. Indeed, the TRPV1 receptor and its mRNA have
been localized to neurons in most of these regions (See
additional file 1: Table 1.). However, regions such as the
NTS appear to express more TRPV1 receptors than that of
cingulate or somatosensory cortices. Considering that the
expression of DRG TRPV1 receptors can be up-regulated
in response to peripheral inflammation [26], it would be
of interest to determine whether TRPV1 receptors of the
ACC and somatosensory cortex can be similarly regulated.
TRPV1 receptor activation in the brain
The effect of TRPV1 receptor activation in a variety of
brain regions has been investigated. These areas include
the following: the ventral medulla, periaqueductal grey,
solitary tract nucleus (NTS), dorsal raphé nucleus, locus
coeruleus, hypothalamus, thalamus, ventral tegmental
area, substantia nigra, hippocampus, cerebellum and cor-
tex. Many of these studies have utilized pharmacological
activation of TRPV1 receptors with capsaicin. In this sec-
tion, the effect of TRPV1 receptor activation in the central
nervous system will be examined and possible synaptic
mechanisms will be addressed.
Ventral medulla
The TRPV1 receptor is involved in the modulation of car-
diovascular, respiratory, and temperature control systems
at the level of the ventrolateral medulla [27,28]. Microin-
jection of capsaicin (0.5–50 nmol) into the ventrolateral
medulla at the level of the hypoglossal nerve roots was
found to increase respiratory output, arterial pressure, and
heart rate in an anesthetized rat preparation [27]. Infusion
of capsaicin into more caudal regions reduced arterial
pressure and heart rate in both anesthetized and chronic
rat preparations [27].
Acute systemic administration of capsaicin results in an
initial hypothermia, followed by hyperthermia [28-30].
The hypothermia is a result of enhancement of autonomic
heat loss mechanisms (e.g. peripheral vasodilation) and a
depression of heat saving mechanisms (e.g. shivering)
[31]. The latent hyperthermia is likely a result of sym-
pathoadrenal activation [29,32]. Osaka et al. [28] found
that lesions of the rostral ventrolateral medulla, a region
containing sympathoadrenal preganglionic neurons,
largely attenuated capsaicin-induced hyperthermia in
anesthetized rats. Consistently, microinjection of capsai-
cin (500 µmol) into the rostral ventrolateral medulla was
found to elicit hyperthermia [28]. The results suggest that
capsaicin activates the rostral ventrolateral medulla which
then increases sympathoadrenal activation leading to heat
production. It will be of interest to determine whether the
actions of capsaicin in this region are specific to the TRPV1
receptor.
Periaqueductal grey
The periaqueductal grey is a well established component
of the pain modulatory circuitry and projects to the rostral
ventromedial medulla [25,33]. The rostral ventromedial
medulla can subsequently exert descending modulation
over nociceptive spinal reflex pathways [33-37]. Palazzo
et al. [38] demonstrated that capsaicin injection (1–6
nmol) at the periaqueductal grey can increase the latency
of nociceptive responses, indicating analgesia. This effect
could be blocked by local antagonism of NMDA and
metabotropic glutamate receptors. In contrast, McGa-
raughty et al. [39] found that capsaicin (10 nmol) injected
into the dorsal periaqueductal grey could decrease the
latency of both nociceptive behavioral responses and ros-
tral ventromedial medulla tail-flick-on cell activity, sug-
gesting hyperalgesia. To account for this discrepancy,
McGaraughty et al. [39] suggested that the fast delivery of
capsaicin by Palazzo et al. [38] may have desensitized the
TRPV1 receptors resulting in analgesia.
A recent investigation by Maione et al. [40] demonstrated
that elevation of endocannabinoid levels, with an inhibi-
tor of fatty acid amide hydrolase, in the ventrolateral peri-
aqueductal grey can produce analgesia and hyperalgesia.
This effect was shown to be dependent on the activation
of TRPV1 and CB1 (cannabinoid receptor-1) receptors.
Low doses of inhibitor at the periaqueductal grey pro-
duced rapid hyperalgesia. The hyperalgesia was proposed
to result from an increase in 2-arachidonoylglycerol,
which stimulates CB1 receptors preferentially over TRPV1
receptors [40]. This leads to descending inhibition of off-
cells and stimulates on-cells in the rostral ventromedial
medulla, speeding up nociceptive responses [40]. Higher
doses of fatty acid amide inhibitor cause rapid analgesia
followed by a delayed hyperalgesia [40]. The findings
were explained by suggesting that anandamide levels
increase and stimulate TRPV1 receptors resulting in anal-
gesia. Subsequently, 2-arachidonoylglycerol levels
increase to stimulate CB1 receptors resulting in hyperalge-
sia. Again, the effects of the inhibitor at the periaqueductal
grey would be mediated through descending modulation
of the appropriate rostral ventromedial medulla circuitry
[40]. Consistent with the concept that these two receptors
modulate descending facilitatory and inhibitory output to
the rostral ventromedial medulla, Maione et al. [40]
found that some neurons of the periaqueductal grey co-
expressed TRPV1 and CB1 receptors.Molecular Pain 2006, 2:34 http://www.molecularpain.com/content/2/1/34
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Nucleus of the solitary tract
Activation of TRPV1 receptors in the NTS has been found
to induce hypotension, bradycardia [41], and reduction of
respiratory rate [42]. In-vitro brainstem slice experiments
demonstrated that acute capsaicin (100 nM) treatment
induces a rapidly developing inward current in NTS neu-
rons. Capsaicin treatment also enhanced spontaneous
glutamatergic currents [43]. The effects of the capsaicin
treatment were restricted to a subpopulation of NTS neu-
rons [43]. Additional evidence suggested that the capsai-
cin was acting on presynaptic TRPV1 receptors to enhance
glutamate release onto AMPA receptors [43]. In addition,
capsaicin sensitive neurons of the NTS, but not insensitive
neurons, can be characterized by large transient outward
currents [44]. The results suggest that within a particular
brain region, activation of TRPV1 receptors may selec-
tively affect neurons characterized by distinct electrophys-
iological properties.
Dorsal raphé nucleus
Peripheral administration of capsaicin results in bursting
activity in the dorsal raphé nucleus, recorded with intrac-
ortical electroencephalogram in rats [45]. In addition,
direct injection of capsaicin (65 nmol) into the dorsal
raphé nucleus increases vasodilation of the skin and
decreases core body temperature in anesthetized rats [46].
Locus coeruleus
The locus coeruleus is activated by painful stimuli and is
involved in the production of antinociception [33,47].
Intravenous administration of capsaicin increases firing
rates of locus coeruleus neurons in anesthetized rats [48].
This increased firing even occurred following neonatal
capsaicin treatment to destroy sensory nerve fibers, indi-
cating a central effect of capsaicin [48]. Consistent with
this excitatory effect, TRPV1 activation at the locus coeru-
leus with capsaicin (1 µM) was found to enhance gluta-
matergic miniature excitatory postsynaptic currents
through a presynaptic mechanism [49].
Hypothalamus
Injection of capsaicin (2–80 nmol) into the preoptic area
of the hypothalamus causes an abrupt hypothermic
response [50], and increases the activity of warm-sensitive
neurons while depressing the activity of cold-sensitive
neurons [30]. In addition, capsaicin (~4 µM) can evoke
glutamate release in rat hypothalamic slice preparations
[13,22] and enhance postsynaptic currents [51] (Fig. 2).
Thalamus
Nociceptive (pinch sensitive) neurons in the medial tha-
lamus can be activated by arterial capsaicin infusion [52-
54], an effect that can be blocked by morphine [54]. Inter-
estingly, TRPV1 gene knockout mice are not impaired in
the detection of noxious mechanical stimuli as deter-
mined by tail pinch, von-Frey test, and spinal nociceptive
neuron responses [12]. However, this does not rule out
the possibility that thalamic TRPV1 receptors modulate
noxious mechanical information once it has been
detected.
Ventral tegmental area
Application of capsaicin (1–10 µM) to the ventral tegmen-
tal area increases the firing rate and bursting activity of
dopaminergic neurons in-vitro [55] (Fig. 3). In addition,
it was shown that activation of TRPV1 receptors of the
ventral tegmental area could enhance dopaminergic out-
put to the nucleus accumbens, following peripheral nox-
ious stimulation [55].
Substantia nigra
Peripheral administration of capsaicin results in bursting
activity in the substantia nigra, recorded with intracortical
electroencephalogram in rats [45]. Injection of capsaicin
into the substantia nigra can enhance locomotor behav-
iors (100 nmol capsaicin) and produce peripheral vasodi-
lation (30–100 nmol capsaicin) [56,57]. In-vitro studies
have demonstrated that TRPV1 activation (1–10 µM cap-
saicin) enhances glutamatergic synaptic transmission to
dopaminergic neurons of the substantia nigra [58]. In
addition, analysis of excitatory postsynaptic currents sug-
gested a presynaptic mechanism for this enhancement
[58]. Importantly, this study demonstrated that TRPV1 is
activated by endogenous ligands in-vitro, since antago-
nism of the receptor reduced the frequency of spontane-
ous excitatory postsynaptic currents.
TRPV1 modulates synaptic events in the hypothalamus Figure 2
TRPV1 modulates synaptic events in the hypothala-
mus. Activation of TRPV1 receptors increases the frequency 
of postsynaptic currents of hypothalamic medial preoptic 
nucleus neurons studied in-vitro. Reprinted from [51] © 2005 
with permission from Elsevier Science.
Vehicle Capsaicin 4 µM
500 pA
100 sec
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Hippocampus
In the hippocampal CA1 region, TRPV1 activation
enhances paired-pulse depression [7,59]. It is possible
that the mechanism of the depression was the activation
of presynaptic TRPV1 receptors at GABAergic terminals,
which feed back and inhibit CA1 neurons [59,60]. This
would be expected to have the net effect of increasing
GABA output [60]. However, TRPV1 receptor activation
was found to inhibit the influx of calcium and reduce
GABA release in synaptosomal hippocampus prepara-
tions [60]. This discrepancy between in-vitro and ex-vivo
data may be a consequence of the disruption of intracellu-
lar or extracellular molecules under ex-vivo conditions.
These molecules may modulate TRPV1 receptor function.
Alternatively, the discrepancy may be due to rapid desen-
sitization of TRPV1 receptors under ex-vivo conditions
[60].
Cerebellum
Microiontophoretically applied capsaicin into the cerebel-
lum depresses neuron spike activity [61]. This finding is
interesting because it differs from the excitatory effect of
capsaicin in other regions of the brain. In contrast with the
hypothalamus and cerebral cortex (below), activation of
the TRPV1 receptor does not evoke glutamate release in
cerebellum tissue slices [13].
Cortex
The somatosensory cortex and ACC are both involved in
the processing of pain [24,25,33,62]. However, few stud-
ies have examined the effect of direct TRPV1 receptor acti-
vation in these regions. It has been shown that activation
of the TRPV1 receptor can evoke glutamate release from
cortical slices [13]. In addition, a study by Toldi et al. [63]
showed that local application of capsaicin to the somato-
sensory cortex reduced mechanically and electrically
evoked potentials of anesthetized rats [63].
Preliminary in-vitro data from our laboratory show that
capsaicin application (50 µM) to the ACC increases the
firing frequency of some neurons (Fig. 4), while depress-
ing firing of other neurons. The differing direction of neu-
ron firing patterns is similar to the effects observed in the
hypothalamic preoptic area [30]. Since the ACC is
involved in the formation of pain-associated memory and
the descending modulation of nociception [64,65], it will
be of interest to determine whether or not the TRPV1
receptor can influence these processes.
Future directions
The TRPV1 receptor is expressed and functional through-
out the brain. It is possible that populations of TRPV1
receptors within the brain are also involved in processing
nociceptive information. This not only suggests that local
manipulation of cortical TRPV1 may lead to alterations in
pain behaviors, but also warns against assigning a strictly
peripheral role of TRPV1 receptors in pain transmission.
For example, since TRPV1 receptor knockout mice have a
global gene deletion, it is not possible to discount the role
of the receptors expressed at supraspinal structures in the
pain phenotypes reported [12].
The most prominent expression of TRPV1 mRNA and
receptors is in the DRG with expression much less concen-
trated in supraspinal structures. While, minor expression
does not necessarily imply minor functions, research will
need to carefully examine the role of the TRPV1 receptors
in the brain. Indeed, many early studies were conducted
without determining the specificity of the capsaicin effect
to the TRPV1 receptor. Future experimentation will need
to confirm the involvement of TRPV1 receptors in the
brain with antagonists and TRPV1-deficient mouse stud-
ies.
Electrophysiological studies indicate that the actions of
the TRPV1 receptor in supraspinal structures are largely
presynaptic [13,22,43,49,58]. However, this receptor is
reported to be localized to postsynaptic spines in the
brain [19]. This inconsistency is likely due to incomplete
analysis of synaptic TRPV1 localization throughout the
whole brain.
TRPV1 modulates spike activity of ventral tegmental area Figure 3
TRPV1 modulates spike activity of ventral tegmental 
area. Dopamine cell recorded in whole cell current clamp 
mode in-vitro slice preparation. Bath application of capsaicin 
(middle trace) augmented firing frequency of ventral tegmen-
tal cells. In some cases bursting activity was observed (right-
most trace and inset). Inset also shows action potentials 
superimposed on depolarizing envelope. These results indi-
cate that TRPV1 activation can directly modulate central 
neurons. Adapted from [55] © 2005 with permission from 
Macmillan Publishers Ltd.
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Capsaicin activates anterior cingulate cortex neurons Figure 4
Capsaicin activates anterior cingulate cortex neurons. A. Current injection (220 pA, 800 ms) into a pyramidal neuron 
in layer II-III in the ACC induced action potential firing. Perfusion of capsaicin (50 µM) significantly increased the number of 
spikes. Note the slight depolarizing effect of capsaicin in the neuron (dashed line). The results indicate that TRPV1 receptors 
are functional in a cortical brain region involved in pain processing. B. Time course of capsaicin effect on the neuron shown in 
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Direct activation of the TRPV1 receptor in different brain
regions can result in diverse effects including changes in
body temperature, respiration, heart rate, blood pressure
and locomotion [27,28,41,42,46,50,56,57]. This indi-
cates that TRPV1 receptor function depends on where it is
located in the brain.
The TRPV1 receptor is not only of interest to the basic neu-
roscientist but also among pharmaceutical industries. The
initial observation that there was little or no expression of
this receptor in the brain suggested that this receptor
would be an ideal target for the treatment of pain.
Although treating pain through the modulation of the
TRPV1 receptor is an exciting prospect, caution should be
exercised when developing drugs to target this receptor
since it is expressed and functional in the brain [3,14-21]
and body [6,13]. More extensive research of supraspinal
TRPV1 receptors is needed to determine its role in synap-
tic transmission and the control of behavior.
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ATP Adenosine triphosphate
DRG Dorsal root ganglion
NTS Solitary tract nucleus
TRPV1 Transient receptor potential vanilloid-1
CB1 Cannabinoid receptor-1
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